Efferocytosis Promotes Suppressive Effects on Dendritic Cells through Prostaglandin E2 Production in the Context of Autoimmunity

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Pujol Autonell, Irma ^a   Ampudia, Rosa Maria ^a   Planas, Raquel ^a   Marin Gallen, Silvia ^a   Carrascal, Jorge ^b   Sanchez, Alex ^c   Marin, Ana ^c   Puig Domingo, Manuel ^d   Pujol Borrell, Ricardo ^c   Verdaguer, Joan ^b   Vives Pi, Marta ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b UNIVERSITY OF LLEIDA   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 6; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; APOPTOSIS; ARTICLE; AUTOIMMUNE DIABETES; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BONE MARROW; CELL FUNCTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DIABETES MELLITUS; EFFEROCYTOSIS; ENDOCYTOSIS; GENE EXPRESSION; GENE EXPRESSION PROFILING; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE PROLIFERATION; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS ISLET CELL; PROSTAGLANDIN SYNTHESIS; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; TRANSCRIPTOMICS;

ANIMALS; AUTOIMMUNITY; CELL PROLIFERATION; DENDRITIC CELLS; DINOPROSTONE; GENE EXPRESSION PROFILING; MICE; MICE, INBRED NOD; PHAGOCYTOSIS; T-LYMPHOCYTES, REGULATORY;

EID: 84877768008     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0063296     Document Type: Article

References (51)

1. Erwig LP, Henson PM, (2007) Immunological consequences of apoptotic cell phagocytosis. Am J Pathol 171: 2-8.
2. Green DR, Ferguson T, Zitvogel L, Kroemer G, (2009) Immunogenic and tolerogenic cell death. Nat Rev Immunol 9: 353-363.
3. Steinman RM, Turley S, Mellman I, Inaba K, (2000) The induction of tolerance by dendritic cells that have captured apoptotic cells. J Exp Med 191: 411-416.
4. Chung EY, Kim SJ, Ma XJ, (2006) Regulation of cytokine production during phagocytosis of apoptotic cells. Cell Res 16: 154-161.
5. Mathis D, Vence L, Benoist C, (2001) beta-Cell death during progression to diabetes. Nature 414: 792-798.
6. Knip M, Siljander H, (2008) Autoimmune mechanisms in type 1 diabetes. Autoimmun Rev 7: 550-557.
7. Marin-Gallen S, Clemente-Casares X, Planas R, Pujol-Autonell I, Carrascal J, et al. (2010) Dendritic cells pulsed with antigen-specific apoptotic bodies prevent experimental type 1 diabetes. Clin Exp Immunol 160: 207-214.
8. O'Brien BA, Geng X, Orteu CH, Huang Y, Ghoreishi M, et al. (2006) A deficiency in the in vivo clearance of apoptotic cells is a feature of the NOD mouse. J Autoimmun 26: 104-115.
9. Faleo G, Fotino C, Bocca N, Molano RD, Zahr-Akrawi E, et al. (2012) Prevention of autoimmune diabetes and induction of beta-cell proliferation in NOD mice by hyperbaric oxygen therapy. Diabetes 61: 1769-1778.
10. Phillips B, Giannoukakis N, Trucco M, (2009) Dendritic cell-based therapy in Type 1 diabetes mellitus. Expert Rev Clin Immunol 5: 325-339.
11. Morelli AE, Larregina AT, (2010) Apoptotic cell-based therapies against transplant rejection: role of recipient's dendritic cells. Apoptosis 15: 1083-1097.
12. Peakman M, von Herrath M, (2010) Antigen-specific immunotherapy for type 1 diabetes: maximizing the potential. Diabetes 59: 2087-2093.
13. Hamaguchi K, Gaskins HR, Leiter EH, (1991) NIT-1, a pancreatic beta-cell line established from a transgenic NOD/Lt mouse. Diabetes 40: 842-849.
14. Lyons AB, Parish CR, (1994) Determination of lymphocyte division by flow cytometry. J Immunol Methods 171: 131-137.
15. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, et al. (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249-264.
16. Smyth GK, (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3: Article3.
17. Benjamini Y, Hochberg Y, (1995) Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc Ser B 57: 289-300.
18. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
19. Voll RE, Herrmann M, Roth EA, Stach C, Kalden JR, et al. (1997) Immunosuppressive effects of apoptotic cells. Nature 390: 350-351.
20. Hilkens CM, Isaacs JD, Thomson AW, (2010) Development of dendritic cell-based immunotherapy for autoimmunity. Int Rev Immunol 29: 156-183.
21. Lauber K, Blumenthal SG, Waibel M, Wesselborg S, (2004) Clearance of apoptotic cells: getting rid of the corpses. Mol Cell 14: 277-287.
22. Korns D, Frasch SC, Fernandez-Boyanapalli R, Henson PM, Bratton DL, (2011) Modulation of macrophage efferocytosis in inflammation. Front Immunol 2: 57.
23. Blachere NE, Darnell RB, Albert ML, (2005) Apoptotic cells deliver processed antigen to dendritic cells for cross-presentation. PLoS Biol 3: e185.
24. Adler AJ, Marsh DW, Yochum GS, Guzzo JL, Nigam A, et al. (1998) CD4+ T cell tolerance to parenchymal self-antigens requires presentation by bone marrow-derived antigen-presenting cells. J Exp Med 187: 1555-1564.
25. Miles K, Heaney J, Sibinska Z, Salter D, Savill J, et al. (2012) A tolerogenic role for Toll-like receptor 9 is revealed by B-cell interaction with DNA complexes expressed on apoptotic cells. Proc Natl Acad Sci U S A 109: 887-892.
26. Kushwah R, Wu J, Oliver JR, Jiang G, Zhang J, et al. (2010) Uptake of apoptotic DC converts immature DC into tolerogenic DC that induce differentiation of Foxp3+ Treg. Eur J Immunol 40: 1022-1035.
27. Lo D, Reilly CR, Scott B, Liblau R, McDevitt HO, et al. (1993) Antigen-presenting cells in adoptively transferred and spontaneous autoimmune diabetes. Eur J Immunol 23: 1693-1698.
28. Lee M, Kim AY, Kang Y, (2000) Defects in the differentiation and function of bone marrow-derived dendritic cells in non-obese diabetic mice. J Korean Med Sci 15: 217-223.
29. Sandahl M, Hunter DM, Strunk KE, Earp HS, Cook RS, (2010) Epithelial cell-directed efferocytosis in the post-partum mammary gland is necessary for tissue homeostasis and future lactation. BMC Dev Biol 10: 122.
30. Creusot RJ, Yaghoubi SS, Chang P, Chia J, Contag CH, et al. (2009) Lymphoid-tissue-specific homing of bone-marrow-derived dendritic cells. Blood 113: 6638-6647.
31. Formby B, Miller N, (1990) Autologous CD4 T-cell responses to ectopic class II major histocompatibility complex antigen-expressing single-cell islet cells: an in vitro insight into the pathogenesis of lymphocytic insulitis in nonobese diabetic mice. Proc Natl Acad Sci U S A 87: 2438-2442.
32. Strid J, Lopes L, Marcinkiewicz J, Petrovska L, Nowak B, et al. (2001) A defect in bone marrow derived dendritic cell maturation in the nonobesediabetic mouse. Clin Exp Immunol 123: 375-381.
33. Emamaullee JA, Davis J, Merani S, Toso C, Elliott JF, et al. (2009) Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice. Diabetes 58: 1302-1311.
34. Keino H, Takeuchi M, Kezuka T, Hattori T, Usui M, et al. (2006) Induction of eye-derived tolerance does not depend on naturally occurring CD4+CD25+ T regulatory cells. Invest Ophthalmol Vis Sci 47: 1047-1055.
35. Hanig J, Lutz MB, (2008) Suppression of mature dendritic cell function by regulatory T cells in vivo is abrogated by CD40 licensing. J Immunol 180: 1405-1413.
36. Goodwin JS, Ceuppens J, (1983) Regulation of the immune response by prostaglandins. J Clin Immunol 3: 295-315.
37. Ruggeri P, Nicocia G, Venza I, Venza M, Valenti A, et al. (2000) Polyamine metabolism in prostaglandin E2-treated human T lymphocytes. Immunopharmacol Immunotoxicol 22: 117-129.
38. Baratelli F, Lin Y, Zhu L, Yang SC, Heuze-Vourc'h N, et al. (2005) Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells. J Immunol 175: 1483-1490.
39. Hancock WW, Polanski M, Zhang J, Blogg N, Weiner HL, (1995) Suppression of insulitis in non-obese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and-10, transforming growth factor-beta, and prostaglandin-E. Am J Pathol 147: 1193-1199.
40. Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, et al. (1998) Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest 101: 890-898.
41. Jozefowski S, Biedron R, Bobek M, Marcinkiewicz J, (2005) Leukotrienes modulate cytokine release from dendritic cells. Immunology 116: 418-428.
42. Nencioni A, Wesselborg S, Brossart P, (2003) Role of peroxisome proliferator-activated receptor gamma and its ligands in the control of immune responses. Crit Rev Immunol 23: 1-13.
43. Roszer T, Menendez-Gutierrez MP, Lefterova MI, Alameda D, Nunez V, et al. (2011) Autoimmune kidney disease and impaired engulfment of apoptotic cells in mice with macrophage peroxisome proliferator-activated receptor gamma or retinoid X receptor alpha deficiency. J Immunol 186: 621-631.
44. Torres-Aguilar H, Aguilar-Ruiz SR, Gonzalez-Perez G, Munguia R, Bajana S, et al. (2010) Tolerogenic dendritic cells generated with different immunosuppressive cytokines induce antigen-specific anergy and regulatory properties in memory CD4+ T cells. J Immunol 184: 1765-1775.
45. Suciu-Foca Cortesini N, Piazza F, Ho E, Ciubotariu R, LeMaoult J, et al. (2001) Distinct mRNA microarray profiles of tolerogenic dendritic cells. Hum Immunol 62: 1065-1072.
46. Morel PA, Srinivas M, Turner MS, Fuschiotti P, Munshi R, et al. (2011) Gene expression analysis of dendritic cells that prevent diabetes in NOD mice: analysis of chemokines and costimulatory molecules. J Leukoc Biol 90: 539-550.
47. Torres-Aguilar H, Blank M, Jara LJ, Shoenfeld Y, (2010) Tolerogenic dendritic cells in autoimmune diseases: crucial players in induction and prevention of autoimmunity. Autoimmun Rev 10: 8-17.
48. Van Elssen CH, Vanderlocht J, Oth T, Senden-Gijsbers BL, Germeraad WT, et al. (2011) Inflammation-restraining effects of prostaglandin E2 on natural killer-dendritic cell (NK-DC) interaction are imprinted during DC maturation. Blood 118: 2473-2482.
49. Muthuswamy R, Mueller-Berghaus J, Haberkorn U, Reinhart TA, Schadendorf D, et al. (2010) PGE(2) transiently enhances DC expression of CCR7 but inhibits the ability of DCs to produce CCL19 and attract naive T cells. Blood 116: 1454-1459.
50. Albert ML, Sauter B, Bhardwaj N, (1998) Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 392: 86-89.
51. Brandmaier AG, Leitner WW, Ha SP, Sidney J, Restifo NP, et al. (2009) High-avidity autoreactive CD4+ T cells induce host CTL, overcome T(regs) and mediate tumor destruction. J Immunother 32: 677-688.